Product successfully added to your shopping cart
translation missing: en.products.wishlist.added_to_wishlist
Qty:
There are item(s) in your cart
BioViva USA Inc is dedicated to improving healthy human longevity through gene therapy.
"BioViva’s core gene therapy technology is the subject of a pending patent application. Among other things, this includes aspects of the fundamental recombinant viral vectors and treatment methods that have been shown to significantly increase longevity, prevent age-related hair loss, increase blood glucose tolerance, increase physical coordination, reduce age-related weight loss, and reverse signs of mitochondrial dysfunction.", Liz Parrish, CEO.
BIOVIVA'S patent pending technology will revolutionize gene therapy delivery. Our bioinformatics platform and the BioKeeper™ Vault will contribute to health predictions and recommendations, precision medicine, and the discovery of novel biomarkers. Helping us create even better therapies for you in the future!
Look for the first, easy to use, data base for disease specific information coming soon. BioViva will soon be welcoming the CodeKeeper™! A powerful tool to put open source genetics into your hands.
Have you ever wondered where your money would have the most significant impact on future generations? Medicine is taking a big leap in the coming years and will help millions live better lives. Investing in the future of healthcare may have a direct effect on your healthspan as well. BioViva USA Inc is a privately held c-corporation seeking like-minded people to create better outcomes in an aging population. We are developing our pipeline to develop cures for complex disease using gene therapies and a multi-omic platform for precise precision medicine. Want to own the biotechnology of the future? Invest in BioViva.